Question to the Department for Business and Trade:

To ask the Secretary of State for Business and Trade, if he will publish the full legal texts establishing the MFN mitigations with the US.

The UK has secured a zero percent tariff on all pharmaceuticals exported to the US - the lowest rate offered to any country. We have also secured preferential terms for the UK’s medical technology exports for three years, meaning no additional new tariffs on medical technologies.

This agreement was supported by the government’s commitment to investing 25% more in new innovative medicines – the first major increase in over two decades – which will support improved access to new medicines for NHS patients.

Further work to finalise underpinning details is ongoing. We will share more information when we are able to.